Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Beth Israel Deaconess Medical Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Brain Inflammation Collaborative
Nordsjaellands Hospital
University of Pittsburgh
National and Kapodistrian University of Athens
Massachusetts General Hospital
Second Affiliated Hospital of Wenzhou Medical University
M.D. Anderson Cancer Center
University of North Carolina, Chapel Hill
Radboud University Medical Center
University of Arkansas
University of Messina
Medical University of Gdansk
Duke University
Janssen Scientific Affairs, LLC
University Hospital, Toulouse
Imperial College London
Assiut University
University Hospital, Toulouse
Northwestern University
Ottawa Hospital Research Institute
Assistance Publique - Hôpitaux de Paris
Region Skane
Global Healthy Living Foundation
Nicolaus Copernicus University
Danone Specialized Nutrition
Hospital Galdakao-Usansolo
University of Alabama at Birmingham
Atara Biotherapeutics
University of Rochester
Shandong University
Assistance Publique - Hôpitaux de Paris
Radboud University Medical Center
Radboud University Medical Center
Changhai Hospital
OMNI Medical Services, LLC
Renmin Hospital of Wuhan University
Nordsjaellands Hospital
University of British Columbia
Central Hospital, Nancy, France
UMC Utrecht
Division of General Surgery , Mt. Sinai Hospital
University of Texas at Austin
Zhujiang Hospital
AstraZeneca
Changi General Hospital
Corporacion Parc Tauli
Hikma Pharmaceuticals LLC